Nanoparticle Delivery of Artesunate Enhances the Anti-tumor Efficiency by Activating Mitochondria-Mediated Cell Apoptosis
Artemisinin and its derivatives were considered to exert a broad spectrum of anti-cancer activities, and they induced significant anti-cancer effects in tumor cells. Artemisinin and its derivatives could be absorbed quickly, and they were widely distributed, selectively killing tumor cells. Since lo...
Saved in:
Published in | Nanoscale research letters Vol. 12; no. 1; pp. 403 - 10 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.12.2017
Springer Nature B.V SpringerOpen |
Subjects | |
Online Access | Get full text |
ISSN | 1931-7573 1556-276X |
DOI | 10.1186/s11671-017-2169-7 |
Cover
Abstract | Artemisinin and its derivatives were considered to exert a broad spectrum of anti-cancer activities, and they induced significant anti-cancer effects in tumor cells. Artemisinin and its derivatives could be absorbed quickly, and they were widely distributed, selectively killing tumor cells. Since low concentrations of artesunate primarily depended on oncosis to induce cell death in tumor cells, its anti-tumor effects were undesirable and limited. To obtain better anti-tumor effects, in this study, we took advantage of a new nanotechnology to design novel artesunate-loaded bovine serum albumin nanoparticles to achieve the mitochondrial accumulation of artesunate and induce mitochondrial-mediated apoptosis. The results showed that when compared with free artesunate’s reliance on oncotic death, artesunate-loaded bovine serum albumin nanoparticles showed higher cytotoxicity and their significant apoptotic effects were induced through the distribution of artesunate in the mitochondria. This finding indicated that artesunate-loaded bovine serum albumin nanoparticles damaged the mitochondrial integrity and activated mitochondrial-mediated cell apoptosis by upregulating apoptosis-related proteins and facilitating the rapid release of cytochrome C. |
---|---|
AbstractList | Abstract Artemisinin and its derivatives were considered to exert a broad spectrum of anti-cancer activities, and they induced significant anti-cancer effects in tumor cells. Artemisinin and its derivatives could be absorbed quickly, and they were widely distributed, selectively killing tumor cells. Since low concentrations of artesunate primarily depended on oncosis to induce cell death in tumor cells, its anti-tumor effects were undesirable and limited. To obtain better anti-tumor effects, in this study, we took advantage of a new nanotechnology to design novel artesunate-loaded bovine serum albumin nanoparticles to achieve the mitochondrial accumulation of artesunate and induce mitochondrial-mediated apoptosis. The results showed that when compared with free artesunate’s reliance on oncotic death, artesunate-loaded bovine serum albumin nanoparticles showed higher cytotoxicity and their significant apoptotic effects were induced through the distribution of artesunate in the mitochondria. This finding indicated that artesunate-loaded bovine serum albumin nanoparticles damaged the mitochondrial integrity and activated mitochondrial-mediated cell apoptosis by upregulating apoptosis-related proteins and facilitating the rapid release of cytochrome C. Artemisinin and its derivatives were considered to exert a broad spectrum of anti-cancer activities, and they induced significant anti-cancer effects in tumor cells. Artemisinin and its derivatives could be absorbed quickly, and they were widely distributed, selectively killing tumor cells. Since low concentrations of artesunate primarily depended on oncosis to induce cell death in tumor cells, its anti-tumor effects were undesirable and limited. To obtain better anti-tumor effects, in this study, we took advantage of a new nanotechnology to design novel artesunate-loaded bovine serum albumin nanoparticles to achieve the mitochondrial accumulation of artesunate and induce mitochondrial-mediated apoptosis. The results showed that when compared with free artesunate's reliance on oncotic death, artesunate-loaded bovine serum albumin nanoparticles showed higher cytotoxicity and their significant apoptotic effects were induced through the distribution of artesunate in the mitochondria. This finding indicated that artesunate-loaded bovine serum albumin nanoparticles damaged the mitochondrial integrity and activated mitochondrial-mediated cell apoptosis by upregulating apoptosis-related proteins and facilitating the rapid release of cytochrome C. Artemisinin and its derivatives were considered to exert a broad spectrum of anti-cancer activities, and they induced significant anti-cancer effects in tumor cells. Artemisinin and its derivatives could be absorbed quickly, and they were widely distributed, selectively killing tumor cells. Since low concentrations of artesunate primarily depended on oncosis to induce cell death in tumor cells, its anti-tumor effects were undesirable and limited. To obtain better anti-tumor effects, in this study, we took advantage of a new nanotechnology to design novel artesunate-loaded bovine serum albumin nanoparticles to achieve the mitochondrial accumulation of artesunate and induce mitochondrial-mediated apoptosis. The results showed that when compared with free artesunate's reliance on oncotic death, artesunate-loaded bovine serum albumin nanoparticles showed higher cytotoxicity and their significant apoptotic effects were induced through the distribution of artesunate in the mitochondria. This finding indicated that artesunate-loaded bovine serum albumin nanoparticles damaged the mitochondrial integrity and activated mitochondrial-mediated cell apoptosis by upregulating apoptosis-related proteins and facilitating the rapid release of cytochrome C.Artemisinin and its derivatives were considered to exert a broad spectrum of anti-cancer activities, and they induced significant anti-cancer effects in tumor cells. Artemisinin and its derivatives could be absorbed quickly, and they were widely distributed, selectively killing tumor cells. Since low concentrations of artesunate primarily depended on oncosis to induce cell death in tumor cells, its anti-tumor effects were undesirable and limited. To obtain better anti-tumor effects, in this study, we took advantage of a new nanotechnology to design novel artesunate-loaded bovine serum albumin nanoparticles to achieve the mitochondrial accumulation of artesunate and induce mitochondrial-mediated apoptosis. The results showed that when compared with free artesunate's reliance on oncotic death, artesunate-loaded bovine serum albumin nanoparticles showed higher cytotoxicity and their significant apoptotic effects were induced through the distribution of artesunate in the mitochondria. This finding indicated that artesunate-loaded bovine serum albumin nanoparticles damaged the mitochondrial integrity and activated mitochondrial-mediated cell apoptosis by upregulating apoptosis-related proteins and facilitating the rapid release of cytochrome C. |
ArticleNumber | 403 |
Author | Liu, Rui Yu, Xiwei Su, Chang Shi, Yijie Zhao, Liang |
Author_xml | – sequence: 1 givenname: Rui surname: Liu fullname: Liu, Rui organization: School of Pharmacy, Jinzhou Medical University – sequence: 2 givenname: Xiwei surname: Yu fullname: Yu, Xiwei organization: School of Pharmacy, Jinzhou Medical University – sequence: 3 givenname: Chang surname: Su fullname: Su, Chang organization: School of Veterinary Medicine, Jinzhou Medical University – sequence: 4 givenname: Yijie surname: Shi fullname: Shi, Yijie email: shiyijie119@163.com organization: School of Pharmacy, Jinzhou Medical University – sequence: 5 givenname: Liang surname: Zhao fullname: Zhao, Liang email: liangzhao79@163.com organization: School of Pharmacy, Jinzhou Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28610396$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kk-P0zAQxSO0iP0DH4ALisSFS8CTxHZ8QapKgZV24QISN8txxq2r1C62U6nfHpd20e5K7Mkj-72fZ-x3WZw577AoXgN5D9CxDxGAcagI8KoGJir-rLgASllVc_brLNeigYpT3pwXlzGuCWk54exFcV53DEgj2EWx_6ac36qQrB6x_ISj3WHYl96Us5AwTk4lLBdupZzGWKYVljOXbJWmjQ_lwhirLTq9L_t9OdPJ7lSyblne2uT1yrshWFXd4mAzZSjnOI7lbOu3yUcbXxbPjRojvjqtV8XPz4sf86_Vzfcv1_PZTaUpa1PVilpQTQUOChQ1fQ01cD6oHo3oNQXVCSNq3TRE5bLTOAgYaoONpoYNQjRXxfWRO3i1lttgNyrspVdW_t3wYSlP40uq2cAQsAOtW2J4j9AaYzTPl5Ne1Jn18cjaTv0GB40uBTU-gD48cXYll34nacs64DQD3p0Awf-eMCa5sVHnd1EO_RQlCCJ4C11zkL59JF37Kbj8VLIBwXjd1kQ8pQJBKSUN7UhWvbnf97-G73KQBfwo0MHHGNBIbVP-S38Yw44SiDwkTh4TJ3Pi5CFxkmcnPHLewZ_y1EdPzFq3xHCv6f-a_gAGE-pp |
CitedBy_id | crossref_primary_10_1039_D0TB01964J crossref_primary_10_1016_j_apsb_2022_03_020 crossref_primary_10_1016_j_biopha_2018_03_132 crossref_primary_10_1016_j_ceramint_2022_01_223 crossref_primary_10_1021_acsabm_3c00169 crossref_primary_10_1002_ange_201907388 crossref_primary_10_1002_smll_201907663 crossref_primary_10_1021_acsomega_1c00755 crossref_primary_10_1093_rb_rbae103 crossref_primary_10_1186_s11671_021_03497_z crossref_primary_10_1016_j_bmcl_2018_05_035 crossref_primary_10_1016_j_canlet_2023_216590 crossref_primary_10_1021_acsomega_0c03361 crossref_primary_10_1007_s13659_018_0162_1 crossref_primary_10_3390_medsci6040100 crossref_primary_10_1039_D2NJ03880C crossref_primary_10_1016_j_jddst_2024_106577 crossref_primary_10_1002_anie_201907388 crossref_primary_10_1016_j_phrs_2018_09_002 crossref_primary_10_1186_s12951_021_01200_z crossref_primary_10_1016_j_ijbiomac_2023_125348 crossref_primary_10_2147_IJN_S242032 crossref_primary_10_3390_pharmaceutics12080748 crossref_primary_10_1021_acsnano_2c10830 crossref_primary_10_1039_D4MD00261J crossref_primary_10_1002_slct_202100819 crossref_primary_10_1080_21691401_2018_1505739 crossref_primary_10_1016_j_actbio_2022_12_071 crossref_primary_10_1186_s11671_018_2445_1 |
Cites_doi | 10.3390/ijms160817394 10.1158/1078-0432.CCR-14-0959 10.1007/s00280-009-1095-5 10.1631/jzus.B1000373 10.1158/0008-5472.CAN-09-3535 10.1007/s10495-014-1051-7 10.18632/oncotarget.3004 10.1016/j.yexcr.2016.06.012 10.2174/138955751512150731113242 10.1371/journal.pone.0094034 10.1016/j.cbi.2014.03.011 10.1007/s13346-015-0246-y 10.2147/IJN.S60764 10.1016/j.biotechadv.2014.07.007 10.1039/C4NR07682F 10.1016/j.ijpharm.2014.01.001 10.3109/10717544.2013.801047 10.1074/jbc.M110.210047 10.1166/jbn.2015.1962 10.1097/CAD.0b013e328364a109 10.1016/j.fct.2011.03.016 10.2147/OTT.S81041 10.2147/IJN.S83402 10.1016/j.blre.2015.03.005 10.18632/oncotarget.2792 10.3892/mmr.2015.3517 10.18632/oncotarget.5422 |
ContentType | Journal Article |
Copyright | The Author(s). 2017 Nanoscale Research Letters is a copyright of Springer, 2017. Copyright Springer Nature B.V. Dec 2017 |
Copyright_xml | – notice: The Author(s). 2017 – notice: Nanoscale Research Letters is a copyright of Springer, 2017. – notice: Copyright Springer Nature B.V. Dec 2017 |
DBID | C6C AAYXX CITATION NPM 7QF 7QO 7QQ 7SC 7SE 7SP 7SR 7TA 7TB 7U5 8BQ 8FD 8FE 8FG 8FH ABJCF ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BGLVJ BHPHI CCPQU D1I DWQXO F28 FR3 GNUQQ H8D H8G HCIFZ JG9 JQ2 KB. KR7 L7M LK8 L~C L~D M7P P64 PDBOC PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s11671-017-2169-7 |
DatabaseName | Springer Nature OA Free Journals CrossRef PubMed Aluminium Industry Abstracts Biotechnology Research Abstracts Ceramic Abstracts Computer and Information Systems Abstracts Corrosion Abstracts Electronics & Communications Abstracts Engineered Materials Abstracts Materials Business File Mechanical & Transportation Engineering Abstracts Solid State and Superconductivity Abstracts METADEX Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection ProQuest Natural Science Collection ProQuest One Community College ProQuest Materials Science Collection ProQuest Central ANTE: Abstracts in New Technology & Engineering Engineering Research Database ProQuest Central Student Aerospace Database Copper Technical Reference Library SciTech Premium Collection Materials Research Database ProQuest Computer Science Collection Materials Science Database Civil Engineering Abstracts Advanced Technologies Database with Aerospace Biological Sciences Computer and Information Systems Abstracts Academic Computer and Information Systems Abstracts Professional Biological Science Database Biotechnology and BioEngineering Abstracts Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database Materials Research Database ProQuest Central Student ProQuest Central Essentials ProQuest Computer Science Collection Computer and Information Systems Abstracts SciTech Premium Collection ProQuest Central China Materials Business File ProQuest One Applied & Life Sciences ProQuest One Sustainability Engineered Materials Abstracts Natural Science Collection Biological Science Collection ProQuest Central (New) ANTE: Abstracts in New Technology & Engineering Aluminium Industry Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Electronics & Communications Abstracts ProQuest Technology Collection Ceramic Abstracts Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest One Academic UKI Edition Solid State and Superconductivity Abstracts Engineering Research Database ProQuest One Academic ProQuest One Academic (New) Technology Collection Technology Research Database Computer and Information Systems Abstracts – Academic ProQuest One Academic Middle East (New) Mechanical & Transportation Engineering Abstracts Materials Science Collection ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Natural Science Collection ProQuest Central Aerospace Database Copper Technical Reference Library Biotechnology Research Abstracts ProQuest Central Korea Materials Science Database Advanced Technologies Database with Aerospace ProQuest Materials Science Collection Civil Engineering Abstracts ProQuest SciTech Collection METADEX Computer and Information Systems Abstracts Professional Materials Science & Engineering Collection Corrosion Abstracts MEDLINE - Academic |
DatabaseTitleList | PubMed Publicly Available Content Database Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering |
EISSN | 1556-276X |
EndPage | 10 |
ExternalDocumentID | oai_doaj_org_article_5c6d6e1e81cc40f7be14fffc7eda0b92 PMC5468175 28610396 10_1186_s11671_017_2169_7 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Liao’ning Educational Committee grantid: L2014339 – fundername: Natural Science Foundation of Liaoning Province grantid: 2015020692; 201602337 funderid: http://dx.doi.org/10.13039/501100005047 – fundername: ; grantid: 2015020692; 201602337 – fundername: ; grantid: L2014339 |
GroupedDBID | -A0 .4S .86 .DC 0R~ 123 29M 2VQ 2WC 4.4 40G 5VS 6NX 8FE 8FG 8FH AAFWJ ABJCF ABMNI ACGFO ACGFS ACIWK ACPRK ADBBV ADINQ ADRAZ AEGXH AENEX AEUYN AFGCZ AFKRA AFPKN AFRAH AHBYD AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS ARCSS BAPOH BBNVY BCNDV BENPR BGLVJ BGNMA BHPHI C1A C24 C6C CAG CCPQU COF CS3 D1I DU5 EBS EDO EJD F5P GROUPED_DOAJ GX1 H13 HCIFZ HH5 HYE HZ~ I09 IAO IPNFZ IZQ KB. KDC KQ8 LK8 M48 M4Y M7P MM. M~E NU0 O5R O5S O9- OK1 P2P PDBOC PGMZT PIMPY PROAC RIG RNS RPM RPX RSV SCM SDH SOJ TR2 TSK TUS U2A ~KM AAYXX CITATION OVT PHGZM PHGZT NPM 7QF 7QO 7QQ 7SC 7SE 7SP 7SR 7TA 7TB 7U5 8BQ 8FD ABUWG AZQEC DWQXO F28 FR3 GNUQQ H8D H8G JG9 JQ2 KR7 L7M L~C L~D P64 PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c564t-49295c59eda1a5fb212177dabef9bc51a89f92c330aa898ced91d2fe3c5f6d993 |
IEDL.DBID | C6C |
ISSN | 1931-7573 |
IngestDate | Wed Aug 27 01:26:46 EDT 2025 Thu Aug 21 13:55:13 EDT 2025 Thu Sep 04 18:05:26 EDT 2025 Fri Jul 18 06:51:05 EDT 2025 Fri Jul 25 11:17:10 EDT 2025 Wed Feb 19 01:59:58 EST 2025 Tue Jul 01 01:14:00 EDT 2025 Thu Apr 24 23:13:25 EDT 2025 Fri Feb 21 02:34:31 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Nanoparticles Oncosis Mitochondrial Artemisinin Apoptosis |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c564t-49295c59eda1a5fb212177dabef9bc51a89f92c330aa898ced91d2fe3c5f6d993 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://doi.org/10.1186/s11671-017-2169-7 |
PMID | 28610396 |
PQID | 1955503580 |
PQPubID | 2034687 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_5c6d6e1e81cc40f7be14fffc7eda0b92 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5468175 proquest_miscellaneous_1909741835 proquest_journals_3196724209 proquest_journals_1955503580 pubmed_primary_28610396 crossref_citationtrail_10_1186_s11671_017_2169_7 crossref_primary_10_1186_s11671_017_2169_7 springer_journals_10_1186_s11671_017_2169_7 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20171200 |
PublicationDateYYYYMMDD | 2017-12-01 |
PublicationDate_xml | – month: 12 year: 2017 text: 20171200 |
PublicationDecade | 2010 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States – name: Heidelberg |
PublicationTitle | Nanoscale research letters |
PublicationTitleAbbrev | Nanoscale Res Lett |
PublicationTitleAlternate | Nanoscale Res Lett |
PublicationYear | 2017 |
Publisher | Springer US Springer Nature B.V SpringerOpen |
Publisher_xml | – name: Springer US – name: Springer Nature B.V – name: SpringerOpen |
References | Zhang, Luo, Li, Tan (CR5) 2015; 8 Besbes, Mirshahi, Pocard, Billard (CR16) 2015; 29 Brahmbhatt, Oppermann, Osterlund, Leber, Andrews (CR19) 2015; 21 Aquino, Perazzo, Maistro (CR11) 2011; 49 Wang, Yang, Chen, Wang, Wang, Luo (CR12) 2014; 219 Williams, Cook (CR15) 2015; 6 Ikoba, Peng, Li, Miller, Yu, Wang (CR24) 2015; 7 Yang, Wang, Wang, Wang, Wang, Chen (CR25) 2014; 32 Du, Zhang, Ma, Ji (CR7) 2010; 65 Smoot, Blechacz, Werneburg, Bronk, Sinicrope, Sirica (CR17) 2010; 70 Yu, Yang, Shi, Su, Liu, Feng, Zhao (CR28) 2015; 10 da Jeong, Song, Lim, Lee, Lim, Nam (CR8) 2015; 6 Yang, Wu (CR1) 2015; 15 Jin, Shen, Zhao, Qin, Liu, Huang (CR6) 2013; 20 Song, Li, Wang, Liao, Zhang (CR26) 2015; 11 Kim, Lee, Kim, Sethi, Ahn (CR2) 2015; 6 Yin, Wang, Wang, Dong, Han, Guan (CR10) 2014; 9 Xu, Li, Peng, Sun, Cheng, Ye (CR9) 2011; 12 Hamacher-Brady, Stein, Turschner, Toegel, Mora, Jennewein (CR13) 2011; 286 Shen, Liu, Zhang, Du, Liang, Song (CR22) 2015; 10 Liu, Zuo, Zuo, Wang (CR3) 2015; 12 Modica-Napolitano, Weissig (CR18) 2015; 16 Pang, Qin, Wu, Wang, Chen (CR20) 2016; 347 Agnihotri, Saraf, Singh, Bigoniya (CR23) 2015; 5 Zhou, Sun, Wang, Chen, Zheng, Lu (CR4) 2013; 24 Kvansakul, Hinds (CR14) 2015; 20 Ibrahim, Ibrahim, Dormoi, Briolant, Pradines, Moreno (CR21) 2014; 464 Zhao, Su, Cui, Shi, Liu, Su (CR27) 2014; 9 JH Du (2169_CR7) 2010; 65 Q Xu (2169_CR9) 2011; 12 N Ibrahim (2169_CR21) 2014; 464 J Agnihotri (2169_CR23) 2015; 5 X Yang (2169_CR1) 2015; 15 S Besbes (2169_CR16) 2015; 29 Y Yang (2169_CR25) 2014; 32 M Jin (2169_CR6) 2013; 20 U Ikoba (2169_CR24) 2015; 7 F Song (2169_CR26) 2015; 11 L Liu (2169_CR3) 2015; 12 E Jeong da (2169_CR8) 2015; 6 MM Williams (2169_CR15) 2015; 6 H Brahmbhatt (2169_CR19) 2015; 21 JS Modica-Napolitano (2169_CR18) 2015; 16 Y Wang (2169_CR12) 2014; 219 X Zhou (2169_CR4) 2013; 24 JY Yin (2169_CR10) 2014; 9 S Shen (2169_CR22) 2015; 10 RL Smoot (2169_CR17) 2010; 70 P Zhang (2169_CR5) 2015; 8 A Hamacher-Brady (2169_CR13) 2011; 286 L Zhao (2169_CR27) 2014; 9 X Yu (2169_CR28) 2015; 10 I Aquino (2169_CR11) 2011; 49 M Kvansakul (2169_CR14) 2015; 20 Y Pang (2169_CR20) 2016; 347 C Kim (2169_CR2) 2015; 6 24704559 - Chem Biol Interact. 2014 Aug 5;219:28-36 26170661 - Int J Nanomedicine. 2015 Jun 30;10:4239-53 26426994 - Oncotarget. 2015 Oct 20;6(32):33046-64 25887155 - Blood Rev. 2015 Sep;29(5):345-50 25109677 - Biotechnol Adv. 2014 Nov 15;32(7):1301-16 25784482 - Oncotarget. 2015 Feb 28;6(6):3519-30 25816175 - Mol Med Rep. 2015 Jul;12(1):1465-72 25838396 - Clin Cancer Res. 2015 Jun 15;21(12):2671-6 25945055 - Onco Targets Ther. 2015 Apr 16;8:845-54 25738364 - Oncotarget. 2015 Feb 28;6(6):4020-35 26648717 - Int J Nanomedicine. 2015 Nov 12;10:7045-56 19690861 - Cancer Chemother Pharmacol. 2010 Apr;65(5):895-902 25398535 - Apoptosis. 2015 Feb;20(2):136-50 26223381 - Drug Deliv Transl Res. 2015 Oct;5(5):489-97 21462379 - J Zhejiang Univ Sci B. 2011 Apr;12(4):247-55 26156539 - Mini Rev Med Chem. 2015;15(12):1011-23 21149439 - J Biol Chem. 2011 Feb 25;286(8):6587-601 24739881 - PLoS One. 2014 Apr 16;9(4):e94034 26301299 - J Biomed Nanotechnol. 2015 Jan;11(1):40-52 25680099 - Nanoscale. 2015 Mar 14;7(10):4291-305 23731485 - Drug Deliv. 2013 Apr-May;20(3-4):127-33 21419820 - Food Chem Toxicol. 2011 Jun;49(6):1335-9 24851048 - Int J Nanomedicine. 2014 May 06;9:2149-56 27327234 - Exp Cell Res. 2016 Oct 1;347(2):251-60 23958790 - Anticancer Drugs. 2013 Oct;24(9):920-7 26230693 - Int J Mol Sci. 2015 Jul 29;16(8):17394-421 24412521 - Int J Pharm. 2014 Apr 10;464(1-2):214-24 20160031 - Cancer Res. 2010 Mar 1;70(5):1960-9 |
References_xml | – volume: 16 start-page: 17394 year: 2015 end-page: 17421 ident: CR18 article-title: Treatment strategies that enhance the efficacy and selectivity of mitochondria-targeted anticancer agents publication-title: Int J Mol Sci doi: 10.3390/ijms160817394 – volume: 21 start-page: 2671 year: 2015 end-page: 2676 ident: CR19 article-title: Molecular pathways, leveraging the BCL-2 interactome to kill cancer cells—mitochondrial outer membrane permeabilization and beyond publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-14-0959 – volume: 65 start-page: 895 year: 2010 end-page: 902 ident: CR7 article-title: Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo publication-title: Cancer Chemother Pharmacol doi: 10.1007/s00280-009-1095-5 – volume: 12 start-page: 1465 year: 2015 end-page: 1472 ident: CR3 article-title: Artesunate induces apoptosis and inhibits growth of Eca109 and Ec9706 human esophageal cancer cell lines in vitro and in vivo publication-title: Mol Med Rep – volume: 12 start-page: 247 year: 2011 end-page: 255 ident: CR9 article-title: Artesunate inhibits growth and induces apoptosis in human osteosarcoma HOS cell line in vitro and in vivo publication-title: J Zhejiang Univ Sci B doi: 10.1631/jzus.B1000373 – volume: 10 start-page: 7045 year: 2015 end-page: 7056 ident: CR28 article-title: Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance publication-title: Int J Nanomedicine – volume: 6 start-page: 33046 year: 2015 end-page: 33064 ident: CR8 article-title: Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis publication-title: Oncotarget – volume: 70 start-page: 1960 year: 2010 end-page: 1969 ident: CR17 article-title: A Bax-mediated mechanism for obatoclax-induced apoptosis of cholangiocarcin- oma cells publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-09-3535 – volume: 20 start-page: 136 year: 2015 end-page: 150 ident: CR14 article-title: The Bcl-2 family, structures, interactions and targets for drug discovery publication-title: Apoptosis doi: 10.1007/s10495-014-1051-7 – volume: 6 start-page: 4020 year: 2015 end-page: 4035 ident: CR2 article-title: Artesunate suppresses tumor growth and induces apoptosis through the modulation of multiple oncogenic cascades in a chronic myeloid leukemia xenograft mouse model publication-title: Oncotarget doi: 10.18632/oncotarget.3004 – volume: 347 start-page: 251 year: 2016 end-page: 260 ident: CR20 article-title: Artesunate induces ROS-dependent apoptosis via a Bax-mediated intrinsic pathway in Huh-7 and Hep3B cells publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2016.06.012 – volume: 15 start-page: 1011 year: 2015 end-page: 1023 ident: CR1 article-title: Main anti-tumor angiogenesis agents isolated from Chinese herbal medicines publication-title: Mini Rev Med Chem doi: 10.2174/138955751512150731113242 – volume: 9 start-page: e94034 year: 2014 ident: CR10 article-title: Subchronic toxicological study of two artemisinin derivatives in dogs publication-title: PLoS One doi: 10.1371/journal.pone.0094034 – volume: 219 start-page: 28 year: 2014 end-page: 36 ident: CR12 article-title: Artesunate induces apoptosis through caspase-dependent and -independent mitochondrial pathways in human myelodysplastic syndrome SKM-1 cells publication-title: Chem Biol Interact doi: 10.1016/j.cbi.2014.03.011 – volume: 5 start-page: 489 year: 2015 end-page: 497 ident: CR23 article-title: Development and evaluation of anti-malarial bio-conjugates, artesunate-loaded nanoerythrosomes publication-title: Drug Deliv Transl Res doi: 10.1007/s13346-015-0246-y – volume: 9 start-page: 2149 year: 2014 end-page: 2156 ident: CR27 article-title: Preparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediation publication-title: Int J Nanomedicine doi: 10.2147/IJN.S60764 – volume: 32 start-page: 1301 year: 2014 end-page: 1316 ident: CR25 article-title: Advances in self-assembled chitosan nanomaterials for drug delivery publication-title: Biotechnol Adv doi: 10.1016/j.biotechadv.2014.07.007 – volume: 7 start-page: 4291 year: 2015 end-page: 4305 ident: CR24 article-title: Nanocarriers in therapy of infectious and inflammatory diseases publication-title: Nanoscale doi: 10.1039/C4NR07682F – volume: 464 start-page: 214 year: 2014 end-page: 224 ident: CR21 article-title: Albumin-bound nanoparticles of practically water-insoluble antimalarial lead greatly enhance its efficacy publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2014.01.001 – volume: 20 start-page: 127 year: 2013 end-page: 133 ident: CR6 article-title: In vivo study of effects of artesunate nanoliposomes on human hepatocellular carcinoma xenografts in nude mice publication-title: Drug Deliv doi: 10.3109/10717544.2013.801047 – volume: 286 start-page: 6587 year: 2011 end-page: 6601 ident: CR13 article-title: Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production publication-title: J Biol Chem doi: 10.1074/jbc.M110.210047 – volume: 11 start-page: 40 year: 2015 end-page: 52 ident: CR26 article-title: Nanocomposite hydrogels and their applications in drug delivery and tissue engineering publication-title: J Biomed Nanotechnol doi: 10.1166/jbn.2015.1962 – volume: 24 start-page: 920 year: 2013 end-page: 927 ident: CR4 article-title: Artesunate inhibits the growth of gastric cancer cells through the mechanism of promoting oncosis both in vitro and in vivo publication-title: Anticancer Drugs doi: 10.1097/CAD.0b013e328364a109 – volume: 49 start-page: 1335 year: 2011 end-page: 1339 ident: CR11 article-title: Genotoxicity assessment of the antimalarial compound artesunate in somatic cells of mice publication-title: Food Chem Toxicol doi: 10.1016/j.fct.2011.03.016 – volume: 8 start-page: 845 year: 2015 end-page: 854 ident: CR5 article-title: Artesunate inhibits the growth and induces apoptosis of human gastric cancer cells by downregulating COX-2 publication-title: Oncol Targets Ther doi: 10.2147/OTT.S81041 – volume: 10 start-page: 4239 year: 2015 end-page: 4253 ident: CR22 article-title: Compound antimalarial ethosomal cataplasm, preparation, evaluation, and mechanism of penetration enhancement publication-title: Int J Nanomedicine doi: 10.2147/IJN.S83402 – volume: 29 start-page: 345 year: 2015 end-page: 350 ident: CR16 article-title: Strategies targeting apoptosis proteins to improve therapy of chronic lymphocytic leukemia publication-title: Blood Rev doi: 10.1016/j.blre.2015.03.005 – volume: 6 start-page: 3519 year: 2015 end-page: 3530 ident: CR15 article-title: Bcl-2 family proteins in breast development and cancer, could Mcl-1 targeting overcome therapeutic resistance? publication-title: Oncotarget doi: 10.18632/oncotarget.2792 – volume: 65 start-page: 895 year: 2010 ident: 2169_CR7 publication-title: Cancer Chemother Pharmacol doi: 10.1007/s00280-009-1095-5 – volume: 20 start-page: 136 year: 2015 ident: 2169_CR14 publication-title: Apoptosis doi: 10.1007/s10495-014-1051-7 – volume: 5 start-page: 489 year: 2015 ident: 2169_CR23 publication-title: Drug Deliv Transl Res doi: 10.1007/s13346-015-0246-y – volume: 9 start-page: e94034 year: 2014 ident: 2169_CR10 publication-title: PLoS One doi: 10.1371/journal.pone.0094034 – volume: 16 start-page: 17394 year: 2015 ident: 2169_CR18 publication-title: Int J Mol Sci doi: 10.3390/ijms160817394 – volume: 347 start-page: 251 year: 2016 ident: 2169_CR20 publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2016.06.012 – volume: 15 start-page: 1011 year: 2015 ident: 2169_CR1 publication-title: Mini Rev Med Chem doi: 10.2174/138955751512150731113242 – volume: 12 start-page: 247 year: 2011 ident: 2169_CR9 publication-title: J Zhejiang Univ Sci B doi: 10.1631/jzus.B1000373 – volume: 464 start-page: 214 year: 2014 ident: 2169_CR21 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2014.01.001 – volume: 286 start-page: 6587 year: 2011 ident: 2169_CR13 publication-title: J Biol Chem doi: 10.1074/jbc.M110.210047 – volume: 32 start-page: 1301 year: 2014 ident: 2169_CR25 publication-title: Biotechnol Adv doi: 10.1016/j.biotechadv.2014.07.007 – volume: 12 start-page: 1465 year: 2015 ident: 2169_CR3 publication-title: Mol Med Rep doi: 10.3892/mmr.2015.3517 – volume: 6 start-page: 4020 year: 2015 ident: 2169_CR2 publication-title: Oncotarget doi: 10.18632/oncotarget.3004 – volume: 6 start-page: 33046 year: 2015 ident: 2169_CR8 publication-title: Oncotarget doi: 10.18632/oncotarget.5422 – volume: 8 start-page: 845 year: 2015 ident: 2169_CR5 publication-title: Oncol Targets Ther doi: 10.2147/OTT.S81041 – volume: 9 start-page: 2149 year: 2014 ident: 2169_CR27 publication-title: Int J Nanomedicine doi: 10.2147/IJN.S60764 – volume: 219 start-page: 28 year: 2014 ident: 2169_CR12 publication-title: Chem Biol Interact doi: 10.1016/j.cbi.2014.03.011 – volume: 49 start-page: 1335 year: 2011 ident: 2169_CR11 publication-title: Food Chem Toxicol doi: 10.1016/j.fct.2011.03.016 – volume: 6 start-page: 3519 year: 2015 ident: 2169_CR15 publication-title: Oncotarget doi: 10.18632/oncotarget.2792 – volume: 29 start-page: 345 year: 2015 ident: 2169_CR16 publication-title: Blood Rev doi: 10.1016/j.blre.2015.03.005 – volume: 70 start-page: 1960 year: 2010 ident: 2169_CR17 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-09-3535 – volume: 21 start-page: 2671 year: 2015 ident: 2169_CR19 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-14-0959 – volume: 10 start-page: 4239 year: 2015 ident: 2169_CR22 publication-title: Int J Nanomedicine doi: 10.2147/IJN.S83402 – volume: 10 start-page: 7045 year: 2015 ident: 2169_CR28 publication-title: Int J Nanomedicine – volume: 11 start-page: 40 year: 2015 ident: 2169_CR26 publication-title: J Biomed Nanotechnol doi: 10.1166/jbn.2015.1962 – volume: 20 start-page: 127 year: 2013 ident: 2169_CR6 publication-title: Drug Deliv doi: 10.3109/10717544.2013.801047 – volume: 7 start-page: 4291 year: 2015 ident: 2169_CR24 publication-title: Nanoscale doi: 10.1039/C4NR07682F – volume: 24 start-page: 920 year: 2013 ident: 2169_CR4 publication-title: Anticancer Drugs doi: 10.1097/CAD.0b013e328364a109 – reference: 26648717 - Int J Nanomedicine. 2015 Nov 12;10:7045-56 – reference: 27327234 - Exp Cell Res. 2016 Oct 1;347(2):251-60 – reference: 21149439 - J Biol Chem. 2011 Feb 25;286(8):6587-601 – reference: 20160031 - Cancer Res. 2010 Mar 1;70(5):1960-9 – reference: 25816175 - Mol Med Rep. 2015 Jul;12(1):1465-72 – reference: 21419820 - Food Chem Toxicol. 2011 Jun;49(6):1335-9 – reference: 23731485 - Drug Deliv. 2013 Apr-May;20(3-4):127-33 – reference: 24851048 - Int J Nanomedicine. 2014 May 06;9:2149-56 – reference: 25398535 - Apoptosis. 2015 Feb;20(2):136-50 – reference: 25738364 - Oncotarget. 2015 Feb 28;6(6):4020-35 – reference: 26426994 - Oncotarget. 2015 Oct 20;6(32):33046-64 – reference: 26170661 - Int J Nanomedicine. 2015 Jun 30;10:4239-53 – reference: 24739881 - PLoS One. 2014 Apr 16;9(4):e94034 – reference: 26156539 - Mini Rev Med Chem. 2015;15(12):1011-23 – reference: 19690861 - Cancer Chemother Pharmacol. 2010 Apr;65(5):895-902 – reference: 25838396 - Clin Cancer Res. 2015 Jun 15;21(12):2671-6 – reference: 26223381 - Drug Deliv Transl Res. 2015 Oct;5(5):489-97 – reference: 26301299 - J Biomed Nanotechnol. 2015 Jan;11(1):40-52 – reference: 26230693 - Int J Mol Sci. 2015 Jul 29;16(8):17394-421 – reference: 23958790 - Anticancer Drugs. 2013 Oct;24(9):920-7 – reference: 24704559 - Chem Biol Interact. 2014 Aug 5;219:28-36 – reference: 25887155 - Blood Rev. 2015 Sep;29(5):345-50 – reference: 21462379 - J Zhejiang Univ Sci B. 2011 Apr;12(4):247-55 – reference: 24412521 - Int J Pharm. 2014 Apr 10;464(1-2):214-24 – reference: 25680099 - Nanoscale. 2015 Mar 14;7(10):4291-305 – reference: 25109677 - Biotechnol Adv. 2014 Nov 15;32(7):1301-16 – reference: 25784482 - Oncotarget. 2015 Feb 28;6(6):3519-30 – reference: 25945055 - Onco Targets Ther. 2015 Apr 16;8:845-54 |
SSID | ssj0047076 |
Score | 2.3324914 |
Snippet | Artemisinin and its derivatives were considered to exert a broad spectrum of anti-cancer activities, and they induced significant anti-cancer effects in tumor... Abstract Artemisinin and its derivatives were considered to exert a broad spectrum of anti-cancer activities, and they induced significant anti-cancer effects... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 403 |
SubjectTerms | Anticancer properties Apoptosis Artemisinin Artesunate Bovine serum albumin Cancer Cattle Cell death Chemistry and Materials Science Cytochrome c Cytotoxicity Derivatives Low concentrations Materials Science Mitochondria Mitochondrial Molecular Medicine Nano Express Nanochemistry Nanoparticles Nanoscale Science and Technology Nanotechnology Nanotechnology and Microengineering Oncosis Proteins Serum albumin Stress concentration Toxicity Tumor cells Tumors |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQnuCAeBNYkJE4gaK1k9iOj2XpaoVUTqy0Nyvxg61UnGqTHvrvmXHSqoUFLtyq2KnsefkbjfMNIe-LIKWVQebWcWxhVmrwOWtzG3QonJS-Yvi98-KrvLyqvlyL64NWX3gnbKQHHgV3Jqx00nNfc2srFlTreRVCsMq7hrU6RV-m2S6ZGmNwpVhqKwfohOdKqHKqZ_JanvVYecAUWuUFlzpXRydSIu6_C23-fmnyl8ppOpAuHpGHE5Kks3EHj8k9H5-QBwf8gk_JFmInJMXjDPrZr_ASxpZ2Ad_y_SYC0KTzeIOa7ylAQTqLwzIfNj-6WzpP5BL4ZSZtt3Rmxz5o8TtdQBCAoBkd2G6-SK0-vKPnfgWLWXfroeuX_TNydTH_dn6ZT70WcitkNYCWCi2s0CBV3ojQwonGlXJN64NureBNrYMubFmyBn7W1jvNXRF8aUWQDkDOc3ISu-hfEhpk2zAP-kcyOeZAc65UkOXViN5UcBlhO3kbOxGRYz-MlUkJSS3NqCIDKjKoIqMy8mH_ynpk4fjb5E-oxP1EJNBOD8CszCRy8y-zysjpzgTM5NW9gQ1BQoeF4zuHMZrBRsEcM_JuPwzuijWYJvpug3_BNBIGlSIjL0aD2i-0qCUW5mVG1JGpHe3keCQubxIluKhkDUAwIx93Rnmw6j8J6tX_ENRrcr9AX0o3fE7JyXC78W8Apw3t2-SSPwGAYTub priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZG9wIPE3cCAxmJJ5A152I7fkCoG50mpFYIMWlvUeLLNqkkXdM-9N9zjpOUFcbeotqJ7HPz5x77O4R8SLyURnrJjI2xhFmqweeMYcZrn1gpXcbxvvN0Js_Os28X4mKPzIa7MHiscoiJIVDbxuB_5EdoKgrWE66_LG4YVo3C7OpQQqPsSyvYz4Fi7AHZh5As-IjsH09m338MsTlTPJSbA9QSMyVU2uc541wetZiRwK21YkksNVM7K1Ug9L8Lhf57mPKvjGpYqE4fk4MeYdJxZxJPyJ6rn5JHt3gHn5ENxFTYLHc96Fc3x8MZG9p4fMu16xoAKJ3UV2gRLQWISMcwa7Za_2qWdBJIJ_DGJq02dGy6-mj1JZ1CcIBgWluwaTYNJUCcpSduDoNZNItV0163z8n56eTnyRnrazAwI2S2Au0lWhihnS3jUvgKxBorZcvKeV0ZEZe59joxacpLeMyNszq2iXepEV5aAD8vyKhuaveKUC-rkjuwCySZ49YBUk5BozpHVKe8jQgf5F2YnqAc62TMi7BRyWXRqagAFRWookJF5OP2lUXHznFf52NU4rYjEmuHH5rlZdGLvBBGWuliGJwxGfeqcnHmvTcKBMArnUTkcDCBovf2toAJwUYPE8p3Nv8x3Yi83zaDG2Nupqxds8ZPcI1EQqmIyMvOoLYDTXKJCXsZEbVjajsz2W2pr68CVbjIZA4AMSKfBqO8Ner_Cer1_ZN4Qx4m6CXhTM8hGa2Wa_cWkNmqete722-KOzey priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELaW5QIHxJvAgozECRRwHrbjA0Jl6WqFVE5U2luU-LFbqeuUJpXov2fGSaotFCRuUexE9jzsbzT2N4S8SZ0QWjgRa5NgCbNMgc9pHWunXGqEsDnD-86zb-J8nn-94BdHZCxvNQiwPRjaYT2p-Xr5_ueP7Sdw-I_B4QvxocVcAgbFMk4ToWJ5i9wO6SI8yZfvkgq5ZKHWHECWJJZcZkOS8-Av9rapwOZ_CIL-eZLyt3Rq2KXO7pN7A7ykk94eHpAj6x-SuzdIBx-RLSyoECn3PegXu8STGVvaOPzKthsP6JNO_RWaQ0sBH9KJ7xZxt7lu1nQaGCfwuiatt3Si--Jo_pLOYGUAYXoDBh3PQv0Pa-ipXcJgVs2qa9pF-5jMz6bfT8_joQBDrLnIO1BdqrjmypoqqbirYZtLpDRVbZ2qNU-qQjmV6ixjFTwW2hqVmNTZTHMnDCCfJ-TYN94-I9SJumIWjAIZ5pixAJMzCaFfgZBOOhMRNsq71AM7ORbJWJYhSilE2auoBBWVqKJSRuTt7pNVT83xr86fUYm7jsiqHV4068tyEHnJtTDCJjA4rXPmZG2T3DmnJQiA1SqNyMloAuVoqSVMCKI8zCYfbMYlDiaaMhWR17tm8GFMzFTeNhv8BVPIIpTxiDztDWo30LQQmK0XEZF7prY3k_0Wv7gKPOE8FwWgw4i8G43yxqj_Jqjn_9X7BbmTotOE8z0n5Lhbb-xLQGld_Sr43i86iTgo priority: 102 providerName: Scholars Portal |
Title | Nanoparticle Delivery of Artesunate Enhances the Anti-tumor Efficiency by Activating Mitochondria-Mediated Cell Apoptosis |
URI | https://link.springer.com/article/10.1186/s11671-017-2169-7 https://www.ncbi.nlm.nih.gov/pubmed/28610396 https://www.proquest.com/docview/1955503580 https://www.proquest.com/docview/3196724209 https://www.proquest.com/docview/1909741835 https://pubmed.ncbi.nlm.nih.gov/PMC5468175 https://doaj.org/article/5c6d6e1e81cc40f7be14fffc7eda0b92 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELbY3QscEG8Cy8pInEARjhPb8bFbWlZIXSFEpb1FiR9spZJUm_TQf8-Mk1YtFCQuVlU7ke2Zsb_J2N8Q8o57KY30MjY2wRRmqQabMyY2XntupXQZw_vOs2t5Nc--3IibgSwa78Lsx--TXH5sMU6ADq-KeSJ1rE7ImYB1F5V5LMfbRTdTLOSRAziSxEqodAhgHn3FwRYUmPqPwcs_T0n-FioNO9D0EXk4QEc66mX9mNxz9RPyYI9Q8CnZwGIJXnDfgn5ySzx1saGNx6dcu64BWdJJfYuibilgPzqqu0XcrX82d3QS2CTwKiatNnRk-sRn9Q86A6uHVbK2oKzxLOT2cJaO3RI6s2pWXdMu2mdkPp18H1_FQ3KF2AiZdSAWroUR2tkyKYWvYAtLlLJl5byujEjKXHvNTZqyEn7mxlmdWO5daoSXFlDNc3JaN7V7SaiXVckcCBzZ45h1AIFTBW5djnBNeRsRtp3vwgzM45gAY1kEDySXRS-iAkRUoIgKFZH3u0dWPe3GvxpfohB3DZExO_wBilQMU14II610CXTOmIx5Vbkk894bBRPAKs0jcr5VgWIw47aAAYEHh5Hio9W4fMFAOdMReburBvvEoEtZu2aNr2AaGYJSEZEXvULtOspziZF4GRF1oGoHIzmsqRe3gQNcZDIH5BeRD1ul3Ov13ybq1X-1fk3uczSacHbnnJx2d2v3BhBYV12Qk4x9hjKfQnl2Obn--u0i2ONF-KYB5SzLoZzz0S81ES-k |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtNAcFWlB-CAeGMosEhwAVm1195d76FCaZsqpU2EUCv1Zux9tJWCHeJEKD_HtzHjR2ig9NZb5F1Hs_Mez-wMIe-YE0ILJ3xtQhxhFimQOa197ZRjRggbB3jfeTQWw9P48xk_2yC_urswWFbZ6cRaUZtS4zfybWQVCfYkUJ-mP3ycGoXZ1W6ERtaOVjA7dYux9mLHkV3-hBCu2jncB3q_Z-xgcLI39NspA77mIp4DfExxzZU1WZhxl4MuD6U0WW6dyjUPs0Q5xTTE_Rn8TLQ1KjTM2UhzJ4zCZkxgAjZj_IDSI5u7g_GXr50tiGVQj7cDLyn0JZdRm1cNE7FdYQYEQ3nps1AoX65ZxnqAwHVe77_Fm39lcGvDePCA3G89WtpvWPAh2bDFI3LvSp_Dx2QJOhyC82YH3bcTLAZZ0tLhW7ZaFODw0kFxgRxYUXBJaR-w7M8X38sZHdRNLvCGKM2XtK-beWzFOR2BMgLlXRiQIX9Ujxyxhu7ZCQAzLafzsrqsnpDTW6HGU9IrysI-J9SJPAss8CE2tQuMBc88Ag5SCXqR0hmPBB2-U902RMe5HJO0DowSkTYkSoFEKZIolR75sHpl2nQDuWnzLhJxtREbedcPytl52qI85VoYYUMATus4cDK3Yeyc0xIQEOSKeWSrY4G01S5VCgeCwBIT2Ncu_xEVj7xdLYPawFxQVthygX8RKGxcFHGPPGsYagUoSwQWCAiPyDVWWzvJ-kpxeVG3JuexSMAh9cjHjimvQP0_RL24-RBvyJ3hyeg4PT4cH70kdxlKTF1PtEV689nCvgKvcJ6_bkWPkm-3Le2_AVpIdhU |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5VRUJwQLxrKLBIcAFZ9Wt3vQeEQpPQUlJxoFJvi72PNlKwQ-wI5a_x65jxIzRQeuvNyq6t2Z1vZmcyszOEvIoc55o77msTYguzWILMae1rJ11kOLdJgPedJ8f84CT5dMpOt8iv_i4MplX2OrFR1KbU-B_5HkJFwHkSyD3XpUV8GY7fz3_42EEKI619O40WIkd29RPct-rd4RB4_TqKxqOv-wd-12HA14wnNdAWSaaZtCYLM-Zy0OOhECbLrZO5ZmGWSicjDT5_Bo-ptkaGJnI21sxxI7EQE6j_GyIGOcFb6uOP_SmQiKBpbAf2UegLJuIuohqmfK_C2Ac68cKPQi59sXEmNq0DLrN3_03b_Ct22xyJ47vkTmfL0kELvntkyxb3ye0LFQ4fkBVob3DL2xl0aGeYBrKipcO3bLUswNSlo-IcsVdRMEbpoKinfr38Xi7oqClvgXdDab6iA912YivO6ATUEKjtwoD0-JOm2Yg1dN_OgJh5Oa_Lalo9JCfXwotHZLsoC7tDqON5FlhAIJazC4wFmzwG7MgU7UfhjEeCfr-V7kqhY0eOmWpcopSrlkUKWKSQRUp45M36lXlbB-SqyR-QieuJWMK7-aFcnKluyxXT3HAbAnFaJ4ETuQ0T55wWsAFBLiOP7PYQUJ1eqRQsCFxKDF1fOvxHSDzycj0MCgOjQFlhyyV-IpBYsihmHnncAmpNaJRyTA3gHhEbUNtYyeZIMT1vipKzhKdginrkbQ_KC1T_b6OeXL2IF-QmyLj6fHh89JTcilBgmkSiXbJdL5b2GZiDdf68kTtKvl23oP8GK-FzsQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nanoparticle+Delivery+of+Artesunate+Enhances+the+Anti-tumor+Efficiency+by+Activating+Mitochondria-Mediated+Cell+Apoptosis&rft.jtitle=Nanoscale+research+letters&rft.au=Liu%2C+Rui&rft.au=Yu%2C+Xiwei&rft.au=Su%2C+Chang&rft.au=Shi%2C+Yijie&rft.date=2017-12-01&rft.pub=Springer+US&rft.issn=1931-7573&rft.eissn=1556-276X&rft.volume=12&rft.issue=1&rft_id=info:doi/10.1186%2Fs11671-017-2169-7&rft.externalDocID=10_1186_s11671_017_2169_7 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1931-7573&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1931-7573&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1931-7573&client=summon |